MFS
ICPT

MSI Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

MSI Financial Services’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
37
– – ﹤0.01% 3267
2016
Q3 		$6K Sell
37
-5
-12% -$788 ﹤0.01% 3077
2016
Q2 		$6K Buy
42
+18
+75% +$2.63K ﹤0.01% 3078
2016
Q1 		$3K Sell
24
-3
-11% -$354 ﹤0.01% 3443
2015
Q4 		$4K Buy
27
+21
+350% +$3.56K ﹤0.01% 3236
2015
Q3 		$1K Buy
6
+5
+500% +$1.1K ﹤0.01% 3038
2015
Q2 		$0 Buy
+1
New +$266 ﹤0.01% 3293

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

MSI Financial Services's ICPT Position: Q4 2016 in Review

MSI Financial Services held its Intercept Pharmaceuticals, Inc. (ICPT) position steady in Q4 2016 at 37 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3267.

MSI Financial Services first reported a position in ICPT in Q2 2015 and has held it in 7 quarters since. The position peaked at $6K in Q3 2016. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • MSI Financial Services held 37 shares of Intercept Pharmaceuticals, Inc. worth $4K as of Q4 2016.
  • MSI Financial Services left its Intercept Pharmaceuticals, Inc. share count unchanged in Q4 2016.
  • Intercept Pharmaceuticals, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3267 holding.
  • MSI Financial Services first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and has held it in 7 quarters since.
  • MSI Financial Services's Intercept Pharmaceuticals, Inc. position peaked at $6K in Q3 2016.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.